These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

333 related items for PubMed ID: 37286948

  • 21. Galactose-Deficient IgA1 B cells in the Circulation of IgA Nephropathy Patients Carry Preferentially Lambda Light Chains and Mucosal Homing Receptors.
    Zachova K, Jemelkova J, Kosztyu P, Ohyama Y, Takahashi K, Zadrazil J, Orsag J, Matousovic K, Galuszkova D, Petejova N, Mestecky J, Raska M.
    J Am Soc Nephrol; 2022 May; 33(5):908-917. PubMed ID: 35115327
    [Abstract] [Full Text] [Related]

  • 22. Diagnostic and prognostic value of galactose-deficient IgA1 in patients with IgA nephropathy: an updated systematic review with meta-analysis.
    Zeng Q, Wang WR, Li YH, Liang Y, Wang XH, Yan L, Yu RH.
    Front Immunol; 2023 May; 14():1209394. PubMed ID: 37671165
    [Abstract] [Full Text] [Related]

  • 23. Associations of ABO blood type and galactose-deficient immunoglobulin A1 with adverse outcomes in patients with IgA nephropathy.
    Wang M, Lv J, Chen P, Yu G, Shi S, Liu L, Zhou X, Xu D, Zhao M, Zhang H.
    Nephrol Dial Transplant; 2021 Jan 25; 36(2):288-294. PubMed ID: 31603230
    [Abstract] [Full Text] [Related]

  • 24. Association Between Galactose-Deficient IgA1 Derived From the Tonsils and Recurrence of IgA Nephropathy in Patients Who Underwent Kidney Transplantation.
    Kawabe M, Yamamoto I, Yamakawa T, Katsumata H, Isaka N, Katsuma A, Nakada Y, Kobayashi A, Koike K, Ueda H, Tanno Y, Koike Y, Miki J, Yamada H, Kimura T, Ohkido I, Tsuboi N, Yamamoto H, Kojima H, Yokoo T.
    Front Immunol; 2020 Jan 25; 11():2068. PubMed ID: 33013875
    [Abstract] [Full Text] [Related]

  • 25. Oxidative stress and galactose-deficient IgA1 as markers of progression in IgA nephropathy.
    Camilla R, Suzuki H, Daprà V, Loiacono E, Peruzzi L, Amore A, Ghiggeri GM, Mazzucco G, Scolari F, Gharavi AG, Appel GB, Troyanov S, Novak J, Julian BA, Coppo R.
    Clin J Am Soc Nephrol; 2011 Aug 25; 6(8):1903-11. PubMed ID: 21784819
    [Abstract] [Full Text] [Related]

  • 26. Effect of Immunosuppressive Drugs on the Changes of Serum Galactose-Deficient IgA1 in Patients with IgA Nephropathy.
    Kim MJ, Schaub S, Molyneux K, Koller MT, Stampf S, Barratt J.
    PLoS One; 2016 Aug 25; 11(12):e0166830. PubMed ID: 27930655
    [Abstract] [Full Text] [Related]

  • 27. Galactose-deficient IgA1 and the corresponding IgG autoantibodies predict IgA nephropathy progression.
    Maixnerova D, Ling C, Hall S, Reily C, Brown R, Neprasova M, Suchanek M, Honsova E, Zima T, Novak J, Tesar V.
    PLoS One; 2019 Aug 25; 14(2):e0212254. PubMed ID: 30794576
    [Abstract] [Full Text] [Related]

  • 28. Serum galactose-deficient-IgA1 and IgG autoantibodies correlate in patients with IgA nephropathy.
    Placzek WJ, Yanagawa H, Makita Y, Renfrow MB, Julian BA, Rizk DV, Suzuki Y, Novak J, Suzuki H.
    PLoS One; 2018 Aug 25; 13(1):e0190967. PubMed ID: 29324897
    [Abstract] [Full Text] [Related]

  • 29. Association of IgG co-deposition with serum levels of galactose-deficient IgA1 in pediatric IgA nephropathy.
    Eison TM, Hastings MC, Moldoveanu Z, Sanders JT, Gaber L, Walker PD, Lau KK, Julian BA, Novak J, Wyatt RJ.
    Clin Nephrol; 2012 Dec 25; 78(6):465-9. PubMed ID: 23006340
    [Abstract] [Full Text] [Related]

  • 30. Galactose-Deficient IgA1 as a Candidate Urinary Marker of IgA Nephropathy.
    Fukao Y, Suzuki H, Kim JS, Jeong KH, Makita Y, Kano T, Nihei Y, Nakayama M, Lee M, Kato R, Chang JM, Lee SH, Suzuki Y.
    J Clin Med; 2022 Jun 02; 11(11):. PubMed ID: 35683557
    [Abstract] [Full Text] [Related]

  • 31. Gut Dysbiosis and Intestinal Barrier Dysfunction Promotes IgA Nephropathy by Increasing the Production of Gd-IgA1.
    Tang Y, Zhu Y, He H, Peng Y, Hu P, Wu J, Sun W, Liu P, Xiao Y, Xu X, Wei M.
    Front Med (Lausanne); 2022 Jun 02; 9():944027. PubMed ID: 35872757
    [Abstract] [Full Text] [Related]

  • 32. Novel lectin-independent approach to detect galactose-deficient IgA1 in IgA nephropathy.
    Yasutake J, Suzuki Y, Suzuki H, Hiura N, Yanagawa H, Makita Y, Kaneko E, Tomino Y.
    Nephrol Dial Transplant; 2015 Aug 02; 30(8):1315-21. PubMed ID: 26109484
    [Abstract] [Full Text] [Related]

  • 33. Comprehensive analysis of aberrantly expressed profiles of mRNA and its relationship with serum galactose-deficient IgA1 level in IgA nephropathy.
    Liu Y, Liu X, Jia J, Zheng J, Yan T.
    J Transl Med; 2019 Sep 23; 17(1):320. PubMed ID: 31547815
    [Abstract] [Full Text] [Related]

  • 34. Relationship between Gd-IgA1 and TNFR1 in IgA nephropathy and IgA vasculitis nephritis in children - multicenter study.
    Mizerska-Wasiak M, Gajewski Ł, Cichoń-Kawa K, Siejko A, Małdyk J, Spława-Neyman A, Zachwieja J, Firszt-Adamczyk A, Stankiewicz R, Drożyńska-Duklas M, Żurowska A, Bieniaś B, Sikora P, Pukajło-Marczyk A, Zwolińska D, Szczepańska M, Pawlak-Bratkowska M, Tkaczyk M, Stelmaszczyk-Emmel A, Pańczyk-Tomaszewska M.
    Cent Eur J Immunol; 2021 Sep 23; 46(2):199-209. PubMed ID: 34764788
    [Abstract] [Full Text] [Related]

  • 35. Serum galactose-deficient immunoglobulin A1 in recurrent immunoglobulin a nephropathy after kidney transplantation: A meta-analysis.
    Gong Z, Tang J, Hu W, Song X, Liu X, Mu J, Su Y.
    Transpl Immunol; 2023 Aug 23; 79():101850. PubMed ID: 37182720
    [Abstract] [Full Text] [Related]

  • 36. Mechanism of Yiqi Yangying Heluo Formula in the Treatment of IgA Nephropathy by Affecting Gd-IgA1 Based on BAFF Molecular Level and T Lymphocyte Immunity.
    Liang Y, Zeng Q, Wang XH, Yan L, Yu RH.
    Biomed Res Int; 2023 Aug 23; 2023():5124034. PubMed ID: 36660452
    [Abstract] [Full Text] [Related]

  • 37. Role of abnormal glycosylated IgA1 and interstitial transformation of glomerular endothelial cells in the development and progression of IgA nephropathy.
    Jia W, Dou W, Wang Q, Zeng H, Shi P, Liu J, Liu Z, Zhang J, Zhang JJ.
    Ital J Pediatr; 2023 May 11; 49(1):54. PubMed ID: 37170272
    [Abstract] [Full Text] [Related]

  • 38. Glomerular Immunodeposits of Patients with IgA Nephropathy Are Enriched for IgG Autoantibodies Specific for Galactose-Deficient IgA1.
    Rizk DV, Saha MK, Hall S, Novak L, Brown R, Huang ZQ, Fatima H, Julian BA, Novak J.
    J Am Soc Nephrol; 2019 Oct 11; 30(10):2017-2026. PubMed ID: 31444275
    [Abstract] [Full Text] [Related]

  • 39. Galactosylation of IgA1 Is Associated with Common Variation in C1GALT1.
    Gale DP, Molyneux K, Wimbury D, Higgins P, Levine AP, Caplin B, Ferlin A, Yin P, Nelson CP, Stanescu H, Samani NJ, Kleta R, Yu X, Barratt J.
    J Am Soc Nephrol; 2017 Jul 11; 28(7):2158-2166. PubMed ID: 28209808
    [Abstract] [Full Text] [Related]

  • 40. Clinical and Epidemiological Study of IgA Nephropathy in the Bulgarian Population: Insights into Disease Presentation and Potential Biomarkers.
    Kostadinova I, Lyubomirova M, Bogov B, Kurteva E, Kyurkchiev D, Todorov T.
    J Pers Med; 2024 Feb 29; 14(3):. PubMed ID: 38541011
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 17.